REPL
Replimune Group, Inc.NASDAQStock$9.79-0.63 (-6.02%)Mkt Cap 821.8MP/E —Div Yield —Beta 0.87Vol 2.1MAvg Vol 2.9M
52W$1.70
$11.63
ETFs That Hold REPL (Replimune Group, Inc.)
1M
-13.39%
3M
+277.43%
6M
+31.79%
YTD
+8.99%
1Y
+205.99%
3Y
-52.17%
5Y
-71.14%
ETFs That Hold REPL
Replimune Group, Inc. is held by 47 ETFs. The largest position by market value is in XBI (State Street SPDR S&P Biotech ETF).
| ETF | Fund Name | Weight |
|---|---|---|
| BBC | Virtus Biotech Clinical Trials ETF | 0.77% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.02% |
| MEDX | Horizon Kinetics Medical ETF | 0.72% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.00% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.06% |
| DFUS | Dimensional U.S. Equity ETF | 0.00% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.00% |
| PQSG | PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF | 0.23% |
| IWMW | iShares Russell 2000 BuyWrite ETF | 0.03% |
| PWS | Pacer WealthShield ETF | 0.05% |
| SZNE | Pacer CFRA-Stovall Equal Weight Seasonal Rotation ETF | 0.00% |
| VIRS | Pacer BioThreat Strategy ETF | 0.00% |
| NIFE | Direxion Fallen Knives ETF | 0.52% |
| VETS | Pacer Military Times Best Employers ETF | 0.00% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.03% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
Excludes leveraged and inverse ETFs.
Frequently Asked Questions
How many ETFs hold REPL?
Replimune Group, Inc. (REPL) is held by 47 ETFs (excluding leveraged and inverse funds). The largest position by market value is in XBI (State Street SPDR S&P Biotech ETF).
What is the largest ETF that holds REPL?
By fund size, XBI (State Street SPDR S&P Biotech ETF) with $10.31B in AUM holds 0.28% of its portfolio in REPL, representing $29.3M in market value.
What percentage of CNCR is REPL?
REPL makes up 3.54% of CNCR (Loncar Cancer Immunotherapy ETF), making it one of the largest positions in that fund.
Is REPL in the S&P 500?
REPL is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.